1. Home
  2. VLY vs DAWN Comparison

VLY vs DAWN Comparison

Compare VLY & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLY
  • DAWN
  • Stock Information
  • Founded
  • VLY 1927
  • DAWN 2018
  • Country
  • VLY United States
  • DAWN United States
  • Employees
  • VLY N/A
  • DAWN N/A
  • Industry
  • VLY Major Banks
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLY Finance
  • DAWN Health Care
  • Exchange
  • VLY Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • VLY 5.2B
  • DAWN 624.8M
  • IPO Year
  • VLY N/A
  • DAWN 2021
  • Fundamental
  • Price
  • VLY $10.58
  • DAWN $7.11
  • Analyst Decision
  • VLY Buy
  • DAWN Strong Buy
  • Analyst Count
  • VLY 12
  • DAWN 7
  • Target Price
  • VLY $11.75
  • DAWN $27.86
  • AVG Volume (30 Days)
  • VLY 7.5M
  • DAWN 960.1K
  • Earning Date
  • VLY 10-23-2025
  • DAWN 10-29-2025
  • Dividend Yield
  • VLY 4.13%
  • DAWN N/A
  • EPS Growth
  • VLY 9.10
  • DAWN N/A
  • EPS
  • VLY 0.78
  • DAWN N/A
  • Revenue
  • VLY $1,603,358,000.00
  • DAWN $187,638,000.00
  • Revenue This Year
  • VLY $33.98
  • DAWN $12.56
  • Revenue Next Year
  • VLY $8.90
  • DAWN $48.02
  • P/E Ratio
  • VLY $13.66
  • DAWN N/A
  • Revenue Growth
  • VLY N/A
  • DAWN 2190.50
  • 52 Week Low
  • VLY $7.48
  • DAWN $5.64
  • 52 Week High
  • VLY $11.10
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • VLY 61.47
  • DAWN 51.59
  • Support Level
  • VLY $10.66
  • DAWN N/A
  • Resistance Level
  • VLY $10.94
  • DAWN $7.58
  • Average True Range (ATR)
  • VLY 0.22
  • DAWN 0.25
  • MACD
  • VLY -0.02
  • DAWN -0.32
  • Stochastic Oscillator
  • VLY 53.26
  • DAWN 91.92

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: